GO:0004832 | valine-tRNA ligase activity | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 1 |
GO:0005739 | mitochondrion | 1.65e-03 | 1.00e+00 | 2.404 | 5 | 32 | 659 |
GO:0006458 | 'de novo' protein folding | 2.87e-03 | 1.00e+00 | 8.446 | 1 | 1 | 2 |
GO:0048742 | regulation of skeletal muscle fiber development | 2.87e-03 | 1.00e+00 | 8.446 | 1 | 1 | 2 |
GO:0004647 | phosphoserine phosphatase activity | 2.87e-03 | 1.00e+00 | 8.446 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 2.87e-03 | 1.00e+00 | 8.446 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 2.87e-03 | 1.00e+00 | 8.446 | 1 | 1 | 2 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 2 | 3 |
GO:0003688 | DNA replication origin binding | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0046696 | lipopolysaccharide receptor complex | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0006563 | L-serine metabolic process | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 3 |
GO:0051082 | unfolded protein binding | 4.36e-03 | 1.00e+00 | 4.317 | 2 | 5 | 70 |
GO:0045292 | mRNA cis splicing, via spliceosome | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 2 | 4 |
GO:0006564 | L-serine biosynthetic process | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 4 |
GO:0005829 | cytosol | 7.00e-03 | 1.00e+00 | 1.450 | 7 | 88 | 1787 |
GO:0006282 | regulation of DNA repair | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 2 | 5 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 2 | 6 |
GO:0070914 | UV-damage excision repair | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 6 |
GO:0043032 | positive regulation of macrophage activation | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 4 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 4 | 7 |
GO:0005845 | mRNA cap binding complex | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 8 |
GO:0032727 | positive regulation of interferon-alpha production | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 8 |
GO:0031011 | Ino80 complex | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 3 | 8 |
GO:0010388 | cullin deneddylation | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 4 | 8 |
GO:0051604 | protein maturation | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 8 |
GO:0010225 | response to UV-C | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 9 |
GO:0001530 | lipopolysaccharide binding | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 9 |
GO:0005095 | GTPase inhibitor activity | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 10 |
GO:0042026 | protein refolding | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 10 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 3 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 4 | 11 |
GO:0008652 | cellular amino acid biosynthetic process | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 2 | 11 |
GO:0008334 | histone mRNA metabolic process | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 1 | 11 |
GO:0005737 | cytoplasm | 1.65e-02 | 1.00e+00 | 1.084 | 8 | 127 | 2633 |
GO:0032733 | positive regulation of interleukin-10 production | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 13 |
GO:0050870 | positive regulation of T cell activation | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 2 | 14 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 4 | 15 |
GO:0003887 | DNA-directed DNA polymerase activity | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 2 | 16 |
GO:0042113 | B cell activation | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 1 | 16 |
GO:0042100 | B cell proliferation | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 1 | 17 |
GO:0031667 | response to nutrient levels | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 2 | 17 |
GO:0031047 | gene silencing by RNA | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 18 |
GO:0006913 | nucleocytoplasmic transport | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 20 |
GO:0032735 | positive regulation of interleukin-12 production | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 1 | 20 |
GO:0034660 | ncRNA metabolic process | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 1 | 20 |
GO:0005654 | nucleoplasm | 3.10e-02 | 1.00e+00 | 1.671 | 4 | 68 | 876 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.11e-02 | 1.00e+00 | 4.987 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 3.11e-02 | 1.00e+00 | 4.987 | 1 | 1 | 22 |
GO:0005743 | mitochondrial inner membrane | 3.14e-02 | 1.00e+00 | 2.824 | 2 | 9 | 197 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 6 | 24 |
GO:0009267 | cellular response to starvation | 3.67e-02 | 1.00e+00 | 4.746 | 1 | 1 | 26 |
GO:0010467 | gene expression | 3.79e-02 | 1.00e+00 | 1.968 | 3 | 49 | 535 |
GO:0032755 | positive regulation of interleukin-6 production | 3.80e-02 | 1.00e+00 | 4.691 | 1 | 1 | 27 |
GO:0032729 | positive regulation of interferon-gamma production | 3.94e-02 | 1.00e+00 | 4.639 | 1 | 1 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.08e-02 | 1.00e+00 | 4.588 | 1 | 4 | 29 |
GO:0006446 | regulation of translational initiation | 4.08e-02 | 1.00e+00 | 4.588 | 1 | 2 | 29 |
GO:0045111 | intermediate filament cytoskeleton | 4.36e-02 | 1.00e+00 | 4.492 | 1 | 3 | 31 |
GO:0042110 | T cell activation | 4.63e-02 | 1.00e+00 | 4.402 | 1 | 2 | 33 |
GO:0003723 | RNA binding | 4.75e-02 | 1.00e+00 | 2.498 | 2 | 22 | 247 |
GO:0007254 | JNK cascade | 4.77e-02 | 1.00e+00 | 4.359 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 5 | 35 |
GO:0006986 | response to unfolded protein | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 1 | 35 |
GO:0031124 | mRNA 3'-end processing | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 4 | 35 |
GO:0044297 | cell body | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 5 | 35 |
GO:0003743 | translation initiation factor activity | 5.18e-02 | 1.00e+00 | 4.237 | 1 | 8 | 37 |
GO:0005905 | coated pit | 5.18e-02 | 1.00e+00 | 4.237 | 1 | 2 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 5.32e-02 | 1.00e+00 | 4.198 | 1 | 4 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 5.32e-02 | 1.00e+00 | 4.198 | 1 | 5 | 38 |
GO:0000775 | chromosome, centromeric region | 5.72e-02 | 1.00e+00 | 4.088 | 1 | 6 | 41 |
GO:0003684 | damaged DNA binding | 5.72e-02 | 1.00e+00 | 4.088 | 1 | 1 | 41 |
GO:0030141 | secretory granule | 6.13e-02 | 1.00e+00 | 3.987 | 1 | 2 | 44 |
GO:0006406 | mRNA export from nucleus | 6.13e-02 | 1.00e+00 | 3.987 | 1 | 7 | 44 |
GO:0051087 | chaperone binding | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 3 | 45 |
GO:0003725 | double-stranded RNA binding | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 2 | 45 |
GO:0002039 | p53 binding | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 4 | 45 |
GO:0009612 | response to mechanical stimulus | 6.40e-02 | 1.00e+00 | 3.922 | 1 | 2 | 46 |
GO:0006310 | DNA recombination | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 8 | 50 |
GO:0006334 | nucleosome assembly | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 4 | 51 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 7.21e-02 | 1.00e+00 | 3.746 | 1 | 8 | 52 |
GO:0006302 | double-strand break repair | 7.21e-02 | 1.00e+00 | 3.746 | 1 | 5 | 52 |
GO:0016311 | dephosphorylation | 7.61e-02 | 1.00e+00 | 3.665 | 1 | 3 | 55 |
GO:0008584 | male gonad development | 7.87e-02 | 1.00e+00 | 3.613 | 1 | 1 | 57 |
GO:0003697 | single-stranded DNA binding | 7.87e-02 | 1.00e+00 | 3.613 | 1 | 4 | 57 |
GO:0042826 | histone deacetylase binding | 8.01e-02 | 1.00e+00 | 3.588 | 1 | 5 | 58 |
GO:0006464 | cellular protein modification process | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 4 | 61 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 4 | 61 |
GO:0050821 | protein stabilization | 8.80e-02 | 1.00e+00 | 3.446 | 1 | 3 | 64 |
GO:0030018 | Z disc | 8.80e-02 | 1.00e+00 | 3.446 | 1 | 3 | 64 |
GO:0044267 | cellular protein metabolic process | 8.86e-02 | 1.00e+00 | 1.987 | 2 | 14 | 352 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 9.19e-02 | 1.00e+00 | 3.380 | 1 | 1 | 67 |
GO:0030308 | negative regulation of cell growth | 9.59e-02 | 1.00e+00 | 3.317 | 1 | 3 | 70 |
GO:0001649 | osteoblast differentiation | 1.01e-01 | 1.00e+00 | 3.237 | 1 | 5 | 74 |
GO:0044822 | poly(A) RNA binding | 1.01e-01 | 1.00e+00 | 1.389 | 3 | 45 | 799 |
GO:0030529 | ribonucleoprotein complex | 1.11e-01 | 1.00e+00 | 3.088 | 1 | 5 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.14e-01 | 1.00e+00 | 3.054 | 1 | 5 | 84 |
GO:0016032 | viral process | 1.23e-01 | 1.00e+00 | 1.705 | 2 | 30 | 428 |
GO:0000209 | protein polyubiquitination | 1.24e-01 | 1.00e+00 | 2.922 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.24e-01 | 1.00e+00 | 2.922 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 1.27e-01 | 1.00e+00 | 2.891 | 1 | 9 | 94 |
GO:0005524 | ATP binding | 1.30e-01 | 1.00e+00 | 1.230 | 3 | 37 | 892 |
GO:0006457 | protein folding | 1.31e-01 | 1.00e+00 | 2.846 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 1.33e-01 | 1.00e+00 | 2.817 | 1 | 6 | 99 |
GO:0016887 | ATPase activity | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 5 | 100 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.41e-01 | 1.00e+00 | 2.732 | 1 | 5 | 105 |
GO:0005769 | early endosome | 1.46e-01 | 1.00e+00 | 2.678 | 1 | 3 | 109 |
GO:0042981 | regulation of apoptotic process | 1.49e-01 | 1.00e+00 | 2.639 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 1.50e-01 | 1.00e+00 | 2.626 | 1 | 6 | 113 |
GO:0000287 | magnesium ion binding | 1.53e-01 | 1.00e+00 | 2.601 | 1 | 4 | 115 |
GO:0007049 | cell cycle | 1.53e-01 | 1.00e+00 | 2.601 | 1 | 8 | 115 |
GO:0000398 | mRNA splicing, via spliceosome | 1.69e-01 | 1.00e+00 | 2.446 | 1 | 15 | 128 |
GO:0005759 | mitochondrial matrix | 1.82e-01 | 1.00e+00 | 2.327 | 1 | 7 | 139 |
GO:0044212 | transcription regulatory region DNA binding | 1.87e-01 | 1.00e+00 | 2.286 | 1 | 13 | 143 |
GO:0005515 | protein binding | 1.94e-01 | 1.00e+00 | 0.436 | 8 | 198 | 4124 |
GO:0001701 | in utero embryonic development | 2.00e-01 | 1.00e+00 | 2.179 | 1 | 7 | 154 |
GO:0005874 | microtubule | 2.10e-01 | 1.00e+00 | 2.097 | 1 | 10 | 163 |
GO:0008380 | RNA splicing | 2.12e-01 | 1.00e+00 | 2.080 | 1 | 21 | 165 |
GO:0016071 | mRNA metabolic process | 2.18e-01 | 1.00e+00 | 2.037 | 1 | 10 | 170 |
GO:0006412 | translation | 2.27e-01 | 1.00e+00 | 1.970 | 1 | 12 | 178 |
GO:0004842 | ubiquitin-protein transferase activity | 2.28e-01 | 1.00e+00 | 1.962 | 1 | 17 | 179 |
GO:0016070 | RNA metabolic process | 2.38e-01 | 1.00e+00 | 1.891 | 1 | 10 | 188 |
GO:0043065 | positive regulation of apoptotic process | 2.54e-01 | 1.00e+00 | 1.788 | 1 | 7 | 202 |
GO:0006281 | DNA repair | 2.55e-01 | 1.00e+00 | 1.781 | 1 | 24 | 203 |
GO:0043234 | protein complex | 2.63e-01 | 1.00e+00 | 1.732 | 1 | 13 | 210 |
GO:0019899 | enzyme binding | 2.63e-01 | 1.00e+00 | 1.732 | 1 | 7 | 210 |
GO:0006200 | ATP catabolic process | 2.72e-01 | 1.00e+00 | 1.671 | 1 | 13 | 219 |
GO:0006355 | regulation of transcription, DNA-templated | 2.74e-01 | 1.00e+00 | 0.964 | 2 | 31 | 715 |
GO:0005634 | nucleus | 3.07e-01 | 1.00e+00 | 0.367 | 6 | 158 | 3246 |
GO:0008285 | negative regulation of cell proliferation | 3.32e-01 | 1.00e+00 | 1.332 | 1 | 11 | 277 |
GO:0009986 | cell surface | 3.45e-01 | 1.00e+00 | 1.261 | 1 | 5 | 291 |
GO:0000278 | mitotic cell cycle | 3.67e-01 | 1.00e+00 | 1.151 | 1 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.70e-01 | 1.00e+00 | 1.138 | 1 | 17 | 317 |
GO:0043066 | negative regulation of apoptotic process | 3.75e-01 | 1.00e+00 | 1.115 | 1 | 8 | 322 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.92e-01 | 1.00e+00 | 1.032 | 1 | 23 | 341 |
GO:0046872 | metal ion binding | 3.93e-01 | 1.00e+00 | 0.579 | 2 | 24 | 934 |
GO:0005509 | calcium ion binding | 4.01e-01 | 1.00e+00 | 0.991 | 1 | 9 | 351 |
GO:0042802 | identical protein binding | 4.04e-01 | 1.00e+00 | 0.978 | 1 | 15 | 354 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.24e-01 | 1.00e+00 | 0.888 | 1 | 21 | 377 |
GO:0070062 | extracellular vesicular exosome | 4.26e-01 | 1.00e+00 | 0.351 | 3 | 51 | 1641 |
GO:0042803 | protein homodimerization activity | 4.66e-01 | 1.00e+00 | 0.705 | 1 | 13 | 428 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.88e-01 | 1.00e+00 | 0.613 | 1 | 29 | 456 |
GO:0016020 | membrane | 5.31e-01 | 1.00e+00 | 0.209 | 2 | 56 | 1207 |
GO:0005730 | nucleolus | 5.36e-01 | 1.00e+00 | 0.197 | 2 | 74 | 1217 |
GO:0005887 | integral component of plasma membrane | 5.73e-01 | 1.00e+00 | 0.279 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 6.00e-01 | 1.00e+00 | 0.175 | 1 | 24 | 618 |
GO:0005615 | extracellular space | 6.20e-01 | 1.00e+00 | 0.100 | 1 | 15 | 651 |
GO:0044281 | small molecule metabolic process | 7.18e-01 | 1.00e+00 | -0.275 | 1 | 35 | 844 |
GO:0005886 | plasma membrane | 7.55e-01 | 1.00e+00 | -0.355 | 2 | 46 | 1784 |
GO:0006351 | transcription, DNA-templated | 8.05e-01 | 1.00e+00 | -0.625 | 1 | 47 | 1076 |